Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Giulia Del Duca
Observed names:
Del Duca Giulia,
G Del Duca
Institutions:
Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani,
Istituti di Ricovero e Cura a Carattere Scientifico
Observed institutions:
University of Rome Tor Vergata,
Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani,
Istituti di Ricovero e Cura a Carattere Scientifico,
Instituto Nazionale Tumori Regina Elena
ORCID:
0009-0004-3408-3817
Observed ORCIDs:
0009-0004-3408-3817,
0009-0008-5720-7738
OpenAlex ID:
A5004326336
What is the impact of post-COVID-19 syndrome on health-related quality of life and associated factors: a cross-sectional analysis
2023
·
Ilaria Mastrorosa
, Giulia Del Duca
, et al.
·
Health and Quality of Life Outcomes
·
58
PDF
Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: prospective cohort study
2024
·
Valentina Mazzotta
, Alessandro Cozzi Lepri
, et al.
·
EClinicalMedicine
·
44
Declining Prevalence of Human Immunodeficiency Virus (HIV)–Associated Neurocognitive Disorders in Recent Years and Associated Factors in a Large Cohort of Antiretroviral Therapy–Treated Individuals With HIV
2022
·
Ilaria Mastrorosa
, Carmela Pinnetti
, et al.
·
Clinical Infectious Diseases
·
41
PDF
Connecting dots of long COVID-19 pathogenesis: a vagus nerve- hypothalamic-pituitary- adrenal-mitochondrial axis dysfunction
2024
·
Marta Camici
, Giulia Del Duca
, et al.
·
Frontiers in Cellular and Infection Microbiology
·
28
PDF
Rapid ART initiation with bictegravir/emtricitabine/tenofovir alafenamide in individuals presenting with advanced HIV disease (Rainbow study)
2023
·
Marta Camici
, Roberta Gagliardini
, et al.
·
International Journal of Antimicrobial Agents
·
17
Early results from implementation of HIV pre-exposure prophylaxis (PrEP) with long-acting injectable cabotegravir for people with barriers to oral strategies, Italy, December 2024 to August 2025
2025
·
Davide Moschese
, Rozenn Esvan
, et al.
·
Eurosurveillance
·
13
PDF
Risk Awareness as a Key Determinant of Early Vaccine Uptake in the Mpox Vaccination Campaign in an Italian Region: A Cross-Sectional Analysis
2023
·
Giulia Del Duca
, Alessandro Tavelli
, et al.
·
Vaccines
·
12
PDF
Reactogenicity and Immunogenicity Against MPXV of the Intradermal Administration of Modified Vaccinia Ankara Compared to the Standard Subcutaneous Route
2024
·
Valentina Mazzotta
, Pierluca Piselli
, et al.
·
Vaccines
·
7
PDF
Impact of switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate to bictegravir/emtricitabine/tenofovir alafenamide on psychiatric symptoms and neurocognition
2024
·
Alessandra Vergori
, Giulia Del Duca
, et al.
·
AIDS
·
5
Mental health, stigma and risk perception among early adopters of HIV PrEP with LA Cabotegravir in Italy: a multicenter cross-sectional and implementation study
2025
·
Giulia Del Duca
, Davide Moschese
, et al.
·
International Journal of Infectious Diseases
·
3
PDF
Switching to bictegravir/emtricitabine/tenofovir alafenamide from efavirenz/emtricitabine/tenofovir disoproxil in virologically suppressed people with HIV: findings from a non-randomized clinical trial (EBONY study)
2025
·
Roberta Gagliardini
, Marta Camici
, et al.
·
International Journal of Infectious Diseases
·
2
PDF
OC72 Comparison of users accessing PrEP in hospital-based or community-based settings: first picture from the PrIDE cohort
2025
·
V Mazzotta
, A Tavelli
, et al.
·
Sexually Transmitted Infections
·
2
Cognitive outcomes and psychological symptoms in an Italian cohort with post-acute COVID-19 condition (PACC)
2024
·
Alessandra Vergori
, Giulia Del Duca
, et al.
·
Heliyon
·
2
Intravenous immunoglobulin treatment for long COVID: a case report of clinical and immunological findings
2026
·
Marta Camici
, Eva Piano Mortari
, et al.
·
The Lancet Infectious Diseases
·
1
SC9 Comparison between the Frascati criteria and Equivalent Scores for the neurocognitive assessment (NCA) of people living with HIV (PWH)
2025
·
G Del Duca
, I Mastrorosa
, et al.
·
Sexually Transmitted Infections
·
1
Neurocognitive and Neuropsychiatric Trajectories in a Post-COVID Cohort: A Descriptive Longitudinal Study
2026
·
Del Duca Giulia
, Camici Marta
, et al.
·
Neurology International
Beyond Fatigue: The Fatigue Assessment Scale as a Potential Indicator of Long COVID Severity
2026
·
Giulia Del Duca
, Marta Franco
, et al.
·
Journal of Clinical Medicine
PDF
Determinants of non-compliance with additional booster doses of the SARS-CoV-2 vaccine in people living with HIV (PWH): An observational study based on a behavioral and epidemiological survey in Rome (Italy)
2025
·
Giulia Del Duca
, Isabella Sperduti
, et al.
·
Human Vaccines & Immunotherapeutics
PDF
Prolonged clinical monitoring of cognitive performance and psychiatric symptoms among PACS
2025
·
Del Duca Giulia
, Camici Marta
, et al.
·
Research Square
PDF
SC8 Neurocognitive impairment over time in people with HIV (PWH) with and without cerebrospinal viral escape (CHVE)
2025
·
C Pinnetti
, G Del Duca
, et al.
·
Sexually Transmitted Infections
OC47 Patient-reported outcomes (PROs) as a measure of satisfaction with long-acting therapy in PWH
2025
·
G Del Duca
, I Sperduti
, et al.
·
Sexually Transmitted Infections
P114 Prolonged clinical monitoring of cognitive performance and psychiatric symptoms among PACS
2025
·
G Del Duca
, I Sperduti
, et al.
·
Sexually Transmitted Infections
OC12 Real-world implementation of long-acting PrEP with injectable cabotegravir: preliminary data from an Italian cohort
2025
·
V Mazzotta
, C Fusetti
, et al.
·
Sexually Transmitted Infections
Show more works
View as search
Works count:
23
Citation count:
236
H-index:
7
I10-index:
7
Year
Topic
Type